Seoul, Seoul-t'ukpyolsi, South Korea The leading representative office of defined VC is situated in the Seoul. The company was established in Asia in South Korea.
The fund is constantly included in less than 2 deals per year. The high activity for fund was in 2019. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 5 partakers. The meaningful sponsors for the fund in investment in the same round are Nau IB Capital, National Pension Service, Korea Development Bank.
Among the most popular fund investment industries, there are Internet, Information Technology. For fund there is a match between the country of its foundation and the country of its the most frequent investments - South Korea. Moreover, a startup needs to be at the age of more than 20 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Megazone Cloud
Related Funds
| Fund Name | Location |
| Avanade | Seattle, United States, Washington |
| Bloc Ventures | England, London, United Kingdom |
| Dyas BV | Netherlands, Utrecht, Utrecht |
| Hangzhou Xinkangjian Venture Capital | China, Hangzhou, Zhejiang |
| India DeepTech | - |
| Innovation Guelph | Canada, Guelph, Ontario |
| Keying Enterprise Management | China, Henan, Zhengzhou |
| Kidstone | China, Hongkou District |
| Labor Dr. Krause & Kollegen MVZ | Germany, Kiel, Schleswig-Holstein |
| MarketEnterprise Co.,Ltd. | Japan, Tokyo |
| MTech Capital | California, Santa Monica, United States |
| Protocol Labs | California, San Francisco, United States |
| Shanghai Boyong Asset Management | China, Shanghai |
| Shanghai Jinjiu Liangchen Touzi Guanli | China, Shanghai |
| Startup Factory | Israel, Tel Aviv, Tel Aviv District |
| Westwood Management | Cincinnati, Ohio, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Mint Collection | $609K | 15 Feb 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Zhiyi Pharmaceutics | $17M | 23 Dec 2020 | Yuexiu District, Guangdong Province, China | ||
MegazoneCloud | $45M | 12 Mar 2019 | South Korea, Gyeonggi-do, South Korea | ||
BCC | 01 Jan 2016 | Beijing, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Mint Collection | $609K | 15 Feb 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Zhiyi Pharmaceutics | $17M | 23 Dec 2020 | Yuexiu District, Guangdong Province, China | ||
MegazoneCloud | $45M | 12 Mar 2019 | South Korea, Gyeonggi-do, South Korea | ||
BCC | 01 Jan 2016 | Beijing, Beijing, China |
